CareRx Corp
TSX:CRRX
Balance Sheet
Balance Sheet Decomposition
CareRx Corp
Current Assets | 65.4m |
Cash & Short-Term Investments | 7m |
Receivables | 36.1m |
Other Current Assets | 22.3m |
Non-Current Assets | 166.5m |
PP&E | 52.1m |
Intangibles | 114.3m |
Current Liabilities | 62.4m |
Accounts Payable | 29.1m |
Accrued Liabilities | 18.4m |
Other Current Liabilities | 14.9m |
Non-Current Liabilities | 87.9m |
Long-Term Debt | 85.1m |
Other Non-Current Liabilities | 2.8m |
Balance Sheet
CareRx Corp
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
0
|
15
|
0
|
0
|
0
|
0
|
20
|
36
|
28
|
7
|
|
Cash Equivalents |
0
|
15
|
0
|
0
|
0
|
0
|
20
|
36
|
28
|
7
|
|
Total Receivables |
47
|
16
|
25
|
16
|
12
|
13
|
15
|
38
|
37
|
36
|
|
Accounts Receivables |
35
|
16
|
17
|
16
|
11
|
12
|
15
|
36
|
36
|
35
|
|
Other Receivables |
12
|
0
|
8
|
0
|
1
|
1
|
1
|
2
|
1
|
1
|
|
Inventory |
5
|
6
|
8
|
7
|
5
|
5
|
9
|
18
|
20
|
20
|
|
Other Current Assets |
38
|
235
|
5
|
1
|
27
|
1
|
2
|
4
|
3
|
3
|
|
Total Current Assets |
90
|
272
|
37
|
25
|
44
|
19
|
45
|
95
|
89
|
65
|
|
PP&E Net |
19
|
12
|
13
|
16
|
12
|
20
|
21
|
38
|
52
|
52
|
|
PP&E Gross |
19
|
12
|
13
|
16
|
12
|
20
|
21
|
38
|
52
|
52
|
|
Accumulated Depreciation |
18
|
11
|
13
|
16
|
10
|
14
|
18
|
18
|
22
|
27
|
|
Intangible Assets |
53
|
34
|
25
|
29
|
24
|
19
|
35
|
55
|
53
|
44
|
|
Goodwill |
144
|
56
|
73
|
70
|
36
|
27
|
52
|
92
|
70
|
70
|
|
Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Long-Term Investments |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
3
|
0
|
0
|
|
Other Long-Term Assets |
8
|
5
|
8
|
3
|
6
|
0
|
0
|
0
|
0
|
0
|
|
Other Assets |
144
|
56
|
73
|
70
|
36
|
27
|
52
|
92
|
70
|
70
|
|
Total Assets |
313
N/A
|
378
+21%
|
155
-59%
|
145
-7%
|
124
-14%
|
87
-30%
|
156
+79%
|
283
+81%
|
265
-6%
|
232
-12%
|
|
Liabilities | |||||||||||
Accounts Payable |
22
|
22
|
11
|
14
|
10
|
12
|
16
|
33
|
30
|
29
|
|
Accrued Liabilities |
19
|
13
|
11
|
7
|
6
|
7
|
9
|
13
|
18
|
18
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
15
|
55
|
34
|
81
|
89
|
46
|
6
|
1
|
10
|
13
|
|
Other Current Liabilities |
3
|
5
|
5
|
3
|
8
|
4
|
12
|
5
|
6
|
2
|
|
Total Current Liabilities |
59
|
94
|
62
|
106
|
113
|
68
|
43
|
53
|
64
|
62
|
|
Long-Term Debt |
276
|
253
|
62
|
0
|
0
|
21
|
80
|
130
|
125
|
85
|
|
Deferred Income Tax |
4
|
9
|
5
|
1
|
0
|
0
|
5
|
5
|
4
|
0
|
|
Minority Interest |
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Liabilities |
8
|
7
|
24
|
18
|
21
|
18
|
17
|
12
|
7
|
3
|
|
Total Liabilities |
348
N/A
|
363
+4%
|
153
-58%
|
125
-18%
|
134
+7%
|
107
-20%
|
145
+35%
|
201
+38%
|
200
0%
|
150
-25%
|
|
Equity | |||||||||||
Common Stock |
105
|
108
|
112
|
129
|
132
|
141
|
190
|
283
|
300
|
323
|
|
Retained Earnings |
164
|
117
|
141
|
138
|
172
|
200
|
218
|
241
|
276
|
282
|
|
Additional Paid In Capital |
16
|
17
|
29
|
29
|
30
|
30
|
31
|
32
|
34
|
34
|
|
Other Equity |
7
|
7
|
3
|
0
|
0
|
9
|
8
|
7
|
7
|
6
|
|
Total Equity |
35
N/A
|
14
N/A
|
3
-82%
|
20
+658%
|
10
N/A
|
20
-94%
|
11
N/A
|
82
+628%
|
64
-22%
|
82
+26%
|
|
Total Liabilities & Equity |
313
N/A
|
378
+21%
|
155
-59%
|
145
-7%
|
124
-14%
|
87
-30%
|
156
+79%
|
283
+81%
|
265
-6%
|
232
-12%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
8
|
8
|
9
|
10
|
11
|
14
|
25
|
46
|
51
|
60
|